By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ilypsa, Inc. 

5301 Patrick Henry Drive

Santa Clara  California  95054  U.S.A.
Phone: 408-200-9500 Fax: 408-200-9700



Symyx Technologies, Inc.  High Throughput Experimentation

Company News
Amgen (AMGN) Completes Acquisition of Ilypsa, Inc. 7/19/2007 12:18:33 PM
Ilypsa, Inc. Announces Promotion of Paul A. Stone to Senior Vice President, General Counsel and Chief Patent Counsel 5/1/2007 12:15:04 PM
Ilypsa, Inc. Completes Enrollment of Phase 2 Clinical Trial of ILY101 For Patients With Chronic Kidney Disease On Hemodialysis 2/6/2007 11:48:40 AM
Ilypsa, Inc. Announces Promotion Of Gerrit Klaerner, Ph.D. To Senior Vice President And Chief Business Officer 12/12/2006 11:41:59 AM
Ilypsa, Inc. Appoints Samuel R. Saks, M.D. To Board Of Directors 12/5/2006 10:55:02 AM
Ilypsa, Inc. Announces Appointment Of William D. Waddill As Chief Financial Officer 10/26/2006 10:39:42 AM
Ilypsa, Inc. And Astellas Pharma Inc. Enter A Licensing Agreement On ILY101 For Treatment Of Hyperphosphatemia In Japan; Astellas To Pay Ilypsa $92 Million 4/27/2006 11:23:51 AM
Ilypsa, Inc. Completes Phase 1 Clinical Trial Of ILY101 For Hyperphosphatemia Associated With Chronic Kidney Disease 4/20/2006 12:01:48 PM
Ilypsa, Inc. Announces Appointment Of Jay P. Shepard As President And CEO 1/5/2006 12:50:45 PM
Ilypsa, Inc. Raises $36 Million For Kidney Drugs10/19/2005 5:11:57 PM